Skip directly to content

PsychSIGN NorCal Conference and Residency Fair

 

 

 

Dear PsychSIGN California Members,

My name is Michael Lee, and I'm currently serving as one of the Regional Co-Chairs of the Psychiatry Student Interest Group Network (PsychSIGN) for California.  I would like to cordially invite you to this year's PsychSIGN's Northern California Regional Conference and Residency Fair which will be on Saturday October 12th, 2013 at the San Francisco's Airport Marriott Waterfront Hotel, sponsored by Psych Congress. 

The official event in which Psych Congress is hosting is titled, Integrating Mental Health in Primary Care Regional Meetings Series, and a full list of the program can be found here or at the end of this email: http://www.psychcongress.com/pcpmentalhealth

Psych Congress has sponsored scholarships for each PsychSIGN member to join the event for free. Hotel room discounts are still being worked out.  

 

I hope you will be able to come learn more about Psychiatry and the Residency Programs in California.

Please let me know at your earliest convenience if this will be a possibility.

If you have any further questions, please do not hesitate to contact me at this email or by phone.

SIGN UP HERE: 

https://docs.google.com/forms/d/1SwcrszsQxJbYw3XLWftNafSEXNNfVVkN2jkDGGEuUJ0/viewform

 

Become a PsychSIGN Member here for free:

https://docs.google.com/forms/d/1D9hImkK0owaUGOpxToG8nVqD6DqbUqOvFU-QLDd-o2M/edit

 

Sincerely,

Michael Lee OMS IV

Western University of Health Sciences

PsychSIGN Regional Co-Chair of California & IT Chair

www.psychsign.org

[Please help spread the word by forwarding this e-mail to your respective student leaders in Psychiatry and posting to your school's facebook pages]

The Psychiatry Student Interest Group Network is a national network of medical students interested in Psychiatry, from those with a rough interest in the brain and mind to those already in the residency application and match process. We connect students across the country to their peers, to psychiatry residents, and to practicing psychiatrists from a broad range of subspecialties. We provide mentoring opportunities, resources for your health and career, and ideas for expanding your interest group.

PsychSIGN holds an annual conference in conjunction with the APA Annual Meeting. The first meeting was held in May 2006 in Toronto, ON and drew over 100 students representing 60 medical schools. In 2013, we hosted our 8th annual conference in San Francisco, California. In addition, PsychSIGN holds a number of regional conferences throughout the year, often in conjunction with professional meetings such as the Institute on Psychiatric Services, the American Medical Association National Meeting, and the Annual Meeting of the Academy of Child and Adolescent Psychiatry.

 

Meeting Agenda

7:00 am – 7:30 am 
Registration

7:30am – 9:00am
Professional Medical Education (non-CME) - Breakfast

9:00 am – 9:30 am 
DSM-5: Incorporating New Developments into Primary Care
Saundra Jain, MA, PsyD, LPC    

  • Review the historical development of the DSM
  • Describe DSM-5 changes of interest to primary care practitioners
  • Utilize practical tips and resources related to DSM-5 in order to improve diagnostic accuracy

9:30 am – 10:30 am 
Use of Scales and Screeners in Primary Care Mental Health: Improving Diagnostic Yield and Improving Outcomes

Saundra Jain, MA, PsyD, LPC

  • Describe the prevalence and frequency of common mental health disorders and repercussions of misdiagnosis
  • Identify overlapping symptoms and comorbidities between common mental health disorders
  • Implement the use of psychiatric scales and screeners in differentiating common mental health disorders and identifying comorbidities

10:30 am – 10:45 am
Morning Break                                                                                                       

10:45 am – 11:45 am
The Hidden Disorder: Bipolar Depression Recognition and Treatment in Primary Care Practice

Vladmir Maletic, MD, MS                    

  • Identify and differentiate bipolar depression from unipolar depression in the primary care setting
  • Outline the neurobiologic and systemic factors of bipolar 1 depression and associated comorbidities
  • Describe the safety and efficacy of available and emerging pharmacotherapies for bipolar 1 depression
  • Consider patient characteristics, adherence, and adverse effect profiles in bipolar 1 depression treatment decisions and specialist referrals

11:45 am – 12:45 pm 
Nonpharmacologic Therapies for Depression and Bipolar Depression in Primary Care Practice
Saundra Jain, MA, PsyD, LPC

  • Examine the need for nonpharmacologic therapies in the treatment of both unipolar depression and bipolar disorder
  • Identify specific nonpharmacologic techniques that for neurobiological reasons are helpful in reducing the suffering of patients
  • Implement the use of specific, practical, and patient friendly tools to fully utilize the benefits of nonpharmacologic treatments to increase remission rates and diminish risk of relapse

12:45 pm – 2:15 pm
Professional Medical Education (non-CME) – Lunch

2:15 pm – 3:15 pm
Receptor Pharmacology in Depression: Update for Primary Care 
Jon W. Draud, MS, MD 

  • Employ measurement-based care to identify and address acute and residual symptoms of major depressive disorder (MDD) and monitor treatment response
  • Optimize clinical and quality of life outcomes through better recognition and management of treatment side effects
  • Improve patient engagement in the pursuit and maintenance of MDD remission
  • Describe the mechanisms of action, including the serotonin system and multi-target agents, of new and investigation agents for MDD
  • Outline clinical data on the benefits and limitations of new and emerging MDD treatment options

3:15 pm – 3:30 pm
Afternoon Break                                                                                                      

3:30 pm – 4:30 pm
Beyond the Syndrome: A Role for Folate in a More Effective, Personalized Treatment of MDD
Vladmir Maletic, MD, MS

  • Discuss the importance of optimizing first-line pharmacotherapy in patients with MDD to achieve remission
  • Summarize clinical evidence for complementary and alternative medicine and folate-based adjunctive therapy in patients with MDD
  • Outline MDD clinical scenarios and patient populations in which utilizing folate-based therapies would be appropriate
  • Implement a personalized approach to the overall treatment plan for patients with MDD

4:30 pm – 5:30 pm [PSYCHSIGN STUDENTS TO GO TO RESIDENCY FAIR]
Bringing It All Together: Case Studies in MDD and Bipolar Depression with Panel Discussion
W. Clay Jackson, MD, DipTh    

  • Review recent changes in the ‘bereavement exception’ codified by DSM-5
  • List advantages of utilizing metrics in the treatment of MDD
  • List advantages and disadvantages of counseling versus medical therapy for MDD patients
  • Discuss recent data pointing to advantages of metabolic treatments in obese patients with MDD

 

Q&A with faculty will follow each session